These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34431506)

  • 1. The influence of lipid digestion on the fate of orally administered drug delivery vehicles.
    Boyd BJ; Clulow AJ
    Biochem Soc Trans; 2021 Aug; 49(4):1749-1761. PubMed ID: 34431506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of lipids on absorption of carvedilol in dogs: Is coadministration of lipids as efficient as a lipid-based formulation?
    Alskär LC; Parrow A; Keemink J; Johansson P; Abrahamsson B; Bergström CAS
    J Control Release; 2019 Jun; 304():90-100. PubMed ID: 31047962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real time evolution of liquid crystalline nanostructure during the digestion of formulation lipids using synchrotron small-angle X-ray scattering.
    Warren DB; Anby MU; Hawley A; Boyd BJ
    Langmuir; 2011 Aug; 27(15):9528-34. PubMed ID: 21678977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How relevant are assembled equilibrium samples in understanding structure formation during lipid digestion?
    Phan S; Salentinig S; Hawley A; Boyd BJ
    Eur J Pharm Biopharm; 2015 Oct; 96():117-24. PubMed ID: 26212786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Situ Lipolysis and Synchrotron Small-Angle X-ray Scattering for the Direct Determination of the Precipitation and Solid-State Form of a Poorly Water-Soluble Drug During Digestion of a Lipid-Based Formulation.
    Khan J; Hawley A; Rades T; Boyd BJ
    J Pharm Sci; 2016 Sep; 105(9):2631-2639. PubMed ID: 26359590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solubilisation behaviour of poorly water-soluble drugs during digestion of solid SMEDDS.
    Vithani K; Hawley A; Jannin V; Pouton C; Boyd BJ
    Eur J Pharm Biopharm; 2018 Sep; 130():236-246. PubMed ID: 29981444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Ferroquine on the Solubilization of Artefenomel (OZ439) during in Vitro Lipolysis in Milk and Implications for Oral Combination Therapy for Malaria.
    Salim M; Khan J; Ramirez G; Murshed M; Clulow AJ; Hawley A; Ramachandruni H; Beilles S; Boyd BJ
    Mol Pharm; 2019 Apr; 16(4):1658-1668. PubMed ID: 30830789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revisiting dispersible milk-drug tablets as a solid lipid formulation in the context of digestion.
    Binte Abu Bakar SY; Salim M; Clulow AJ; Hawley A; Boyd BJ
    Int J Pharm; 2019 Jan; 554():179-189. PubMed ID: 30391337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Lipid Digestion and Drug Permeation/Re-Dissolution on Absorption of Orally Administered Ritonavir as Different Lipid-Based Formulations.
    Tanaka Y; Doi H; Katano T; Kasaoka S
    Eur J Pharm Sci; 2021 Feb; 157():105604. PubMed ID: 33098990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digestion of Lipid-Based Formulations Not Only Mediates Changes to Absorption of Poorly Soluble Drugs Due to Differences in Solubilization But Also Reflects Changes to Thermodynamic Activity and Permeability.
    Tanaka Y; Nguyen TH; Suys EJA; Porter CJH
    Mol Pharm; 2021 Apr; 18(4):1768-1778. PubMed ID: 33729806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of lipid-based formulations for oral administration of poorly water-soluble drug fenofibrate: effects of digestion.
    Mohsin K
    AAPS PharmSciTech; 2012 Jun; 13(2):637-46. PubMed ID: 22547370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water-soluble drugs II. In-vivo evaluation.
    Nguyen TH; Hanley T; Porter CJ; Larson I; Boyd BJ
    J Pharm Pharmacol; 2010 Jul; 62(7):856-65. PubMed ID: 20636873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural development of self nano emulsifying drug delivery systems (SNEDDS) during in vitro lipid digestion monitored by small-angle X-ray scattering.
    Fatouros DG; Deen GR; Arleth L; Bergenstahl B; Nielsen FS; Pedersen JS; Mullertz A
    Pharm Res; 2007 Oct; 24(10):1844-53. PubMed ID: 17458683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid Compositions in Infant Formulas Affect the Solubilization of Antimalarial Drugs Artefenomel (OZ439) and Ferroquine during Digestion.
    Salim M; Ramirez G; Peng KY; Clulow AJ; Hawley A; Ramachandruni H; Beilles S; Boyd BJ
    Mol Pharm; 2020 Jul; 17(7):2749-2759. PubMed ID: 32574056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small-volume
    Khan NF; Salim M; Binte Abu Bakar SY; Ristroph K; Prud'homme RK; Hawley A; Boyd BJ; Clulow AJ
    Int J Pharm X; 2022 Dec; 4():100113. PubMed ID: 35243327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained absorption of delamanid from lipid-based formulations as a path to reduced frequency of administration.
    Ramirez G; Pham AC; Clulow AJ; Salim M; Hawley A; Boyd BJ
    Drug Deliv Transl Res; 2021 Jun; 11(3):1236-1244. PubMed ID: 32935235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functions of lipids for enhancement of oral bioavailability of poorly water-soluble drugs.
    Nanjwade BK; Patel DJ; Udhani RA; Manvi FV
    Sci Pharm; 2011; 79(4):705-27. PubMed ID: 22145101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-based formulations and drug supersaturation: harnessing the unique benefits of the lipid digestion/absorption pathway.
    Williams HD; Trevaskis NL; Yeap YY; Anby MU; Pouton CW; Porter CJ
    Pharm Res; 2013 Dec; 30(12):2976-92. PubMed ID: 23824582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid determination of drug solubilization versus supersaturation in natural and digested lipids.
    Gautschi N; Bergström CA; Kuentz M
    Int J Pharm; 2016 Nov; 513(1-2):164-174. PubMed ID: 27609663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational Models of the Gastrointestinal Environment. 2. Phase Behavior and Drug Solubilization Capacity of a Type I Lipid-Based Drug Formulation after Digestion.
    Birru WA; Warren DB; Han S; Benameur H; Porter CJ; Pouton CW; Chalmers DK
    Mol Pharm; 2017 Mar; 14(3):580-592. PubMed ID: 27936778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.